Published in Med Klin (Munich) on July 18, 2009
Rare is frequent and frequent is costly: rare diseases as a challenge for health care systems. Eur J Health Econ (2015) 1.00
Staff costs of hospital-based outpatient care of patients with cystic fibrosis. Health Econ Rev (2011) 0.75
A transcriptional network in polycystic kidney disease. EMBO J (2004) 2.21
German recommendations on health economic evaluation: third and updated version of the Hanover Consensus. Value Health (2008) 2.20
The role of biosimilars in the treatment of rheumatic diseases. Ann Rheum Dis (2012) 2.03
Non-invasive measurement of liver and pancreas fibrosis in patients with cystic fibrosis. J Cyst Fibros (2013) 1.66
Influence of pharmacogenomic profiling prior to pharmaceutical treatment in metastatic colorectal cancer on cost effectiveness : a systematic review. Pharmacoeconomics (2013) 1.51
Methods for determining cost-benefit ratios for pharmaceuticals in Germany. Eur J Health Econ (2007) 1.49
Direct glucocorticoid receptor-Stat5 interaction in hepatocytes controls body size and maturation-related gene expression. Genes Dev (2007) 1.45
A versatile toolkit to produce sensitive FRET biosensors to visualize signaling in time and space. Sci Signal (2013) 1.37
Glucocorticoid receptor function in hepatocytes is essential to promote postnatal body growth. Genes Dev (2004) 1.30
Indirect cost assessment in patients with rheumatoid arthritis (RA): comparison of data from the health economic patient questionnaire HEQ-RA and insurance claims data. Arthritis Rheum (2005) 1.24
The SWI/SNF chromatin-remodeling complex subunit SNF5 is essential for hepatocyte differentiation. EMBO J (2005) 1.23
Cross-sectional validity of the EQ-5D-Y as a generic health outcome instrument in children and adolescents with cystic fibrosis in Germany. BMC Pediatr (2009) 1.04
Role of the hepatocyte nuclear factor-1beta (HNF-1beta) C-terminal domain in Pkhd1 (ARPKD) gene transcription and renal cystogenesis. J Biol Chem (2005) 1.00
Chirped arrays of refractive ellipsoidal microlenses for aberration correction under oblique incidence. Opt Express (2005) 0.99
Cost-effectiveness of targeted therapy with cetuximab in patients with K-ras wild-type colorectal cancer presenting with initially unresectable metastases limited to the liver in a German setting. Clin Ther (2011) 0.96
Detailed functional characterization of glycosylated and nonglycosylated variants of malaria vaccine candidate PfAMA1 produced in Nicotiana benthamiana and analysis of growth inhibitory responses in rabbits. Plant Biotechnol J (2014) 0.94
Patient-reported health care utilization in rheumatoid arthritis: what level of detail is required? Arthritis Rheum (2004) 0.93
Health care costs and their predictors of inflammatory bowel diseases in Germany. Eur J Health Econ (2010) 0.92
Cystic kidney diseases: learning from animal models. Nephrol Dial Transplant (2004) 0.90
Decision-analytic modeling to evaluate the long-term effectiveness and cost-effectiveness of HPV-DNA testing in primary cervical cancer screening in Germany. GMS Health Technol Assess (2010) 0.90
Quality assessment of expert answers to lay questions about cystic fibrosis from various language zones in Europe: the ECORN-CF project. BMC Med Res Methodol (2012) 0.90
Quality of life as an outcome in Alzheimer's disease and other dementias--obstacles and goals. BMC Neurol (2009) 0.90
Ini1/hSNF5 is dispensable for retrovirus-induced cytoplasmic accumulation of PML and does not interfere with integration. FEBS Lett (2004) 0.90
[Costs of ambulatory care for RA patients in Germany]. Med Klin (Munich) (2005) 0.90
[Comparative cost analysis of outpatient and inpatient rehabilitation for cardiac diseases]. Herz (2008) 0.89
Measuring economic consequences of preterm birth - Methodological recommendations for the evaluation of personal burden on children and their caregivers. Health Econ Rev (2011) 0.88
Plant-based production of recombinant Plasmodium surface protein pf38 and evaluation of its potential as a vaccine candidate. PLoS One (2013) 0.86
Cost of illness in rheumatoid arthritis in Germany in 1997-98 and 2002: cost drivers and cost savings. Rheumatology (Oxford) (2010) 0.86
Genome sequencing: a systematic review of health economic evidence. Health Econ Rev (2013) 0.85
Malaria vaccine candidate antigen targeting the pre-erythrocytic stage of Plasmodium falciparum produced at high level in plants. Biotechnol J (2014) 0.85
Comparison of estimated medical costs among patients who are defined as having rheumatoid arthritis using three different standards. Eur J Health Econ (2004) 0.85
A carcinoembryonic antigen-specific diabody produced in tobacco. FASEB J (2002) 0.83
Cost-effectiveness of TNF-alpha-blocking agents in the treatment of rheumatoid arthritis. Expert Opin Pharmacother (2004) 0.82
Biologic TNF inhibiting agents for treatment of inflammatory rheumatic diseases: dosing patterns and related costs in Switzerland from a payers perspective. Health Econ Rev (2012) 0.82
Cost of transfusion-dependent myelodysplastic syndrome (MDS) from a German payer's perspective. Ann Hematol (2010) 0.81
Virtual endoscopy of the tracheo-bronchial system: sub-millimeter collimation with the 16-row multidetector scanner. Eur Radiol (2004) 0.81
Impact of radiofrequency ablation for patients with varicose veins on the budget of the German statutory health insurance system. Health Econ Rev (2013) 0.81
Cost-effectiveness of primarily human papillomavirus-based cervical cancer screening in settings with currently established Pap screening: a systematic review commissioned by the German Federal Ministry of Health. Int J Technol Assess Health Care (2008) 0.81
Diffusion of innovations: treatment of Alzheimer's disease in Germany. Health Policy (2002) 0.81
Outpatient medication costs of patients with cystic fibrosis in Germany. Appl Health Econ Health Policy (2010) 0.81
Distinct cell-specific expression of homospermidine synthase involved in pyrrolizidine alkaloid biosynthesis in three species of the boraginales. Plant Physiol (2012) 0.80
Critical function of Ikaros in controlling Aiolos gene expression. FEBS Lett (2007) 0.80
[Incremental cost-effectiveness of dipyridamole + acetylsalicylic acid in secondary prevention of ischemic noncardioembolic stroke]. Med Klin (Munich) (2009) 0.80
Biologic TNF inhibiting agents for treatment of rheumatoid arthritis: persistence and dosing patterns in Germany. Health Econ Rev (2014) 0.80
A structured review and guide through studies on health-related quality of life in kidney cancer, hepatocellular carcinoma, and leukemia. Cancer Invest (2010) 0.80
Considerations about the effectiveness and cost effectiveness of therapies in the treatment of hyperphosphataemia. Health Econ Rev (2011) 0.80
Cost Effectiveness of Exemestane versus Tamoxifen in Post-Menopausal Women with Early Breast Cancer in Germany. Breast Care (Basel) (2009) 0.79
Cost effectiveness of ulcerative colitis treatment in Germany: a comparison of two oral formulations of mesalazine. BMC Health Serv Res (2011) 0.79
Modeling rheumatoid arthritis using different techniques - a review of model construction and results. Health Econ Rev (2014) 0.79
Lipopolysaccharide binding protein, cytokine production in whole blood, and lipoproteins in cystic fibrosis. Pediatr Res (2005) 0.78
[Persistence and frequency of prescriptions of subcutaneous allergen-specific immunotherapy (SCIT) prescribed within the German statutory health insurance]. Med Klin (Munich) (2009) 0.78
Optimization of a multi-stage, multi-subunit malaria vaccine candidate for the production in Pichia pastoris by the identification and removal of protease cleavage sites. Biotechnol Bioeng (2014) 0.78
Prolonged TSH receptor A subunit immunization of female mice leads to a long-term model of Graves' disease, tachycardia, and cardiac hypertrophy. Endocrinology (2015) 0.78
Review on the medical and health economic evidence for an inclusion of colposcopy in primary screening programs for cervical cancer. GMS Health Technol Assess (2007) 0.78
Serum leptin and cytokines in whole blood in relation to clinical and nutritional status in cystic fibrosis. J Pediatr Gastroenterol Nutr (2006) 0.78
A health-economic evaluation of disease-modifying drugs for the treatment of relapsing-remitting multiple sclerosis from the German societal perspective. Clin Ther (2010) 0.77
Resource usage in outpatient care and reimbursement for cystic fibrosis in Germany. Pediatr Pulmonol (2010) 0.77
Antioxidant properties of cystic fibrosis sputum. Am J Physiol Lung Cell Mol Physiol (2005) 0.76
Patient perspective on the management of atrial fibrillation in five European countries. BMC Cardiovasc Disord (2013) 0.76
[Mediastinal ultrasound: technique and possible applications]. Med Klin (Munich) (2002) 0.76
Indirect medical costs in the first 3 years of rheumatoid arthritis: comparison of current methodological approaches. Expert Rev Pharmacoecon Outcomes Res (2002) 0.75
Why is it so difficult to evaluate nursing interventions in dementia? Dement Geriatr Cogn Dis Extra (2012) 0.75
Methods of economic evaluation for the German statutory healthcare system. Pharmacoeconomics (2009) 0.75
High-throughput quantification of stabilizers in polymeric materials by flow injection tandem mass spectrometry. Rapid Commun Mass Spectrom (2014) 0.75
[44th Congress of the German Society for Pneumology, Mar 26-29, 2003 and Munich. Recent findings from and pneumology section of the Society]]. Pneumologie (2003) 0.75
[Human papilloma virus (HPV) testing for cervical carcinoma screening]. Z Evid Fortbild Qual Gesundhwes (2010) 0.75
Best supportive care from the conservative/non-surgical perspective and its costs in the treatment of patients with advanced medullary thyroid cancer: results of a Delphi panel. Oncol Res Treat (2014) 0.75
Fabrication of microoptical freeform arrays on wafer level for imaging applications. Opt Express (2015) 0.75
Cost-effectiveness of TNF-α inhibition in active ankylosing spondylitis: a systematic appraisal of the literature. Expert Rev Pharmacoecon Outcomes Res (2012) 0.75
[Aspects of outpatient palliative care and assessment of the nursing workload. Survey among care givers in Germany]. Pflege Z (2010) 0.75